Expert Review of Neurotherapeutics

Papers
(The TQCC of Expert Review of Neurotherapeutics is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
The role of Fecal Microbiota Transplantation (FMT) in treating patients with multiple sclerosis42
Steps to manage treatment-refractory migraine in adults39
The latest developments with internet-based psychological treatments for depression39
Where Art Thou O treatment for diabetic neuropathy: the sequel36
Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease33
The influence of anxiety and depression on headache in adolescent migraineurs: a case-control study31
Laser interstitial thermal therapy for recurrent brain metastases following stereotactic radiosurgery: a systematic review29
Neuroprotective strategies in multiple sclerosis: a status update and emerging paradigms27
The relevance of cortical thickness in migraine sufferers and implications to therapy27
The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives26
How have the recent updated epilepsy classifications impacted on diagnosis and treatment?25
Neonatal seizures treatment based on conventional multichannel EEG monitoring: an overview of therapeutic options25
New and emerging pharmacotherapeutic options for the treatment of lennox-gastaut syndrome: moving forward in 202523
Immunomodulatory effects and clinical benefits of intravenous immunoglobulin in myasthenia gravis22
Managing antipsychotic-related sexual dysfunction in patients with schizophrenia22
Does electrical stimulation still have a place in the treatment armamentarium for Bell’s palsy?22
Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents22
An overview of the differences in the pharmacological management of post-traumatic stress disorder between women and men22
Advances in the treatment and management of frontotemporal dementia22
Uncertainties in anti-amyloid monoclonal antibody therapy for Alzheimer’s disease: the challenges ahead21
Why is ADHD so difficult to diagnose in older adults?21
Acute and long-term cognitive impairment following sepsis: mechanism and prevention21
Hesitancies in primary headaches treatments20
An overview of ganaxolone as a treatment for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder20
Electroconvulsive therapy in patients with trauma and personality disorders: what is the evidence?19
Clinical Insights and Strategies to Managing Depression Subtypes Associated with Tobacco dependence: A Response to the Letter to the Editor19
Correction19
Spinal automaticity of movement control and its role in recovering function after spinal injury19
Treating subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: an update of the literature18
Epilepsy surgery for seizure control in individuals with Dravet syndrome: is it a safe and practical option?18
Diagnosing epileptic seizures in patients with Alzheimer’s disease and deciding on the appropriate treatment plan18
Emerging role for radiomics in the management of intracranial arteriovenous and cavernous malformations17
Current and emerging diagnostic and management approaches for idiopathic intracranial hypertension17
An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms17
Mindfulness as a therapeutic option for obsessive-compulsive disorder17
Advances in the early diagnosis of amyotrophic lateral sclerosis16
Current use of neurotoxins for alleviating symptoms of cervical dystonia16
The differential diagnosis of autism spectrum disorder in adults16
Multimodal approaches to the treatment of personality disorder16
Virtual reality technology in the treatment of anxiety – progress and future challenges16
Comparison of the retention rate, safety, and efficacy of two different titration protocols for lamotrigine in newly diagnosed epilepsy patients16
Diagnostic advances and challenges in meningioma15
Considerations for hormonal therapy in migraine patients: a critical review of current practice15
Essential Tremor – Deep Brain Stimulation vs. Focused Ultrasound15
The impact of sleep apnea on epilepsy treatment outcomes15
Current perspectives on the diagnosis, assessment, and management of vasculitic neuropathy15
Advances in gene therapy for high-grade glioma: a review of the clinical evidence14
Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review14
Distinguishing essential tremor from Parkinson’s disease: clinical and experimental tools14
Persistent post-concussion syndrome: pathophysiology, diagnosis, current and evolving treatment strategies13
Illuminating the way: the role of bright light therapy in the treatment of depression13
A novel treatment option for intrajejunal levodopa administration13
Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective12
Cross-national reflections on medicinal cannabis and depression12
Developing personalized treatment strategies for Parkinson’s disease based on disease subtypes12
Advancements in neuroactive peptides in seizures12
Long-term outcomes in refractory status epilepticus12
Revisiting stimulant use for emotional dysregulation in attention-deficit/hyperactivity disorder (ADHD)12
Using oral topiramate for primary generalized and focal-to-bilateral tonic-clonic seizures in patients 2 years of age and older: a review of the literature12
Pathogenesis of comorbid epilepsy in Alzheimer’s disease and use of perampanel, an AMPA receptor inhibitor12
Considering hearing loss as a modifiable risk factor for dementia12
Frontotemporal dementia. How to deal with its diagnostic complexity?12
Trends in disease-modifying therapy use in patients with multiple sclerosis using a 10-year population-based cohort study in France12
Psychotherapeutic treatments for generalized anxiety disorder: cognitive and behavioral therapies, enhancement strategies, and emerging efforts12
Developments in the prediction of cognitive changes following deep brain stimulation in persons with Parkinson’s disease11
Managing impulse control and related behavioral disorders in Parkinson’s disease: where we are in 2025?11
Advances in the diagnosis of pediatric arterial ischemic stroke – imaging and beyond11
Updated review of rescue treatments for seizure clusters and prolonged seizures11
Profiling aducanumab as a treatment option for Alzheimer’s disease: an overview of efficacy, safety and tolerability11
The effectiveness of electroconvulsive therapy (ECT) for people with bipolar disorder: is there a specific role?11
Current perspectives on the recognition and diagnosis of low CSF pressure headache syndromes10
Why lithium should be used in patients with bipolar disorder? A scoping review and an expert opinion paper10
Combinations of dextromethorphan for the treatment of mood disorders - a review of the evidence10
Teriflunomide: an oral therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis10
Family accommodation: a diagnostic feature of obsessive-compulsive disorder?10
Radiosurgical thalamotomy for essential tremor: state of the art, current challenges and future directions10
Could self-reporting sleep duration become an important tool in the prediction of dementia?10
An update on the role of magnetic resonance imaging in predicting and monitoring multiple sclerosis progression10
Bipolar disorder staging and the impact it has on its management: an update10
Therapeutic issues in Guillain–Barré syndrome9
Efficacy analysis of three brain stimulation techniques for Alzheimer’s disease: a meta-analysis of repeated transcranial magnetic stimulation, transcranial direct current stimulation, and deep brain 9
Neuromodulation as a treatment strategy in Lennox-Gastaut syndrome: evidence and future directions9
Imaging of infectious and inflammatory cystic lesions of the brain, a narrative review9
Long-term central nervous system (CNS) consequences of COVID-19 in children9
Imaging protocols for non-traumatic spinal cord injury: current state of the art and future directions9
Stem cell therapy for patients with paraplegia: is there hope for the future?9
Pharmacological and non-pharmacological treatment options for sleep disturbances in Alzheimer’s disease9
Rethinking the role of trazodone in the different depressive dimensions9
Meniere disease subtyping: the direction of diagnosis and treatment in the future9
Developments in targeting calcitonin gene-related peptide9
Novel approaches for the treatment of frontotemporal dementia: is there hope for the future?9
Cognitive or daily stress association with headache and pain induction in migraine and tension-type headache patients: a systematic review9
The pivotal role of central sensitization in long COVID, fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome9
Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions9
The major challenges with pharmacologic management of chronic traumatic encephalopathy8
Tobacco use disorder and depression: emerging strategies and recommendations:8
Risk of suicide and suicide-related events in subjects treated with antiseizure medications8
What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?8
Learnings in developmental and epileptic encephalopathies: what do we know?8
Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s disease8
The benefits and risks of escalation versus early highly effective treatment in patients with multiple sclerosis8
Combination of noninvasive brain stimulation and constraint-induced movement therapy in patients with stroke: a systematic review and meta-analysis8
Contemporary perspectives in cerebral amyloid angiopathy8
Important context missing from “contemporary perspectives in cerebral amyloid angiopathy”8
Deep brain stimulation: new programming algorithms and teleprogramming8
Insulin signaling in the central nervous system, a possible pathophysiological mechanism of anesthesia-induced delayed neurocognitive recovery/postoperative neurocognitive disorder: a narrative review8
Ublituximab-xiiy as a treatment option for relapsing multiple sclerosis8
Omaveloxolone for the treatment of Friedreich ataxia: clinical trial results and practical considerations8
What are the main challenges in the treatment of neonatal hypoxic ischemic encephalopathy?8
Suicide and suicidal behaviors: insight into clinical challenges and preventive measures8
0.12902402877808